CompletedPhase 4

Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing

Turkey (Türkiye)80 participantsStarted 2007-08

Plain-language summary

The purpose of this study is to determine whether OM-85 BV (Broncho-Vaxom)has any effect on respiratory infections, infection related wheezing attacks, beta-2 agonist use, duration of attacks and effect on serum cytokine levels.

Who can participate

Age range6 Months – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with recurrent wheezing who had at least 3 wheezing attacks in the last 6 months * Children with asthma who had at least 3 wheezing attacks in the last 6 months Exclusion Criteria: * Chronic lung disease * Immun deficiency * Malabsorption * Anatomic abnormalities of the respiratory tract * Gastroesophageal reflux disease

What they're measuring

Mean Rate of Wheezing Attacks

Timeframe: 12 months

Trial details

NCT IDNCT00733226

SponsorKecioren Education and Training Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-09

Results submitted2009-12-16

View on ClinicalTrials.gov More Asthma trials